Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Health Law Jan 2011 The Role of Practice Guidelines in Medical Malpractice Litigation Timothy K. Mackey, MAS and Bryan A. Liang, MD, JD, PhD Studies show that clinical practice guidelines, used by an accused physician or by patients alleging a breach of standard care, have an impact on case outcomes. Virtual Mentor. 2011;13(1):36-41. doi: 10.1001/virtualmentor.2011.13.1.hlaw1-1101. Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Health Law Jan 2011 The Role of Practice Guidelines in Medical Malpractice Litigation Timothy K. Mackey, MAS and Bryan A. Liang, MD, JD, PhD Studies show that clinical practice guidelines, used by an accused physician or by patients alleging a breach of standard care, have an impact on case outcomes. Virtual Mentor. 2011;13(1):36-41. doi: 10.1001/virtualmentor.2011.13.1.hlaw1-1101.
Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.